Isolation of pseudoprototimosaponin AIII from rhizomes of Anemarrhena asphodeloides and its hypoglycemic activity in streptozotocin-induced diabetic mice

J Nat Prod. 1993 Mar;56(3):345-50. doi: 10.1021/np50093a006.

Abstract

A hot-H2O extract of rhizomes of Anemarrhena asphodeloides, the Japanese sino-medicine "chimo," lowered the blood glucose level in alloxan-diabetic mice. Hypoglycemic activity-guided fractionation isolated a new glycoside, pseudoprototimosaponin AIII [1], which was compared with chemically known prototimosaponin AIII [2]. These compounds exhibited hypoglycemic effects in a dose-dependent manner in streptozotocin-diabetic mice but showed no effects on glucose uptake and insulin release, suggesting that the hypoglycemic mechanism may be due to inhibition of hepatic gluconeogenesis and/or glycogenolysis.

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Diabetes Mellitus, Experimental / drug therapy*
  • Dose-Response Relationship, Drug
  • Glyburide / pharmacology
  • Hypoglycemic Agents / isolation & purification*
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • In Vitro Techniques
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Magnetic Resonance Spectroscopy
  • Male
  • Mice
  • Mice, Inbred Strains
  • Plants, Medicinal / chemistry*
  • Rats
  • Rats, Wistar
  • Saponins / isolation & purification*
  • Saponins / pharmacology
  • Saponins / therapeutic use

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Saponins
  • pseudoprototimosaponin AIII
  • Glyburide